Purpose. The aim of this paper is to report on the implementation of new guidelines on the use of injectable iodinated contrast media (ICM) at our workplace and specific protocols for the preparation of patients at risk. Materials and methods. Operators received training with continuing medical education (CME) credits. The new documentation (patient history/screening form and informed consent form) is available on the hospital Web site and requests serum creatinine determination with estimation of glomerular filtration rate (GFR) for every patient. Additional tests are required for high-risk patients only. Results. Attendance rates were 57.2% among referring physicians and 74.5% among Radiology Department personnel. The Cockcroft-Gault formula was used to estimate GFR in adults. The main problem encountered in the implementation process was that referring physicians failed to evaluate the GFR in 80% of patients, with low GFR being discovered in the Radiology Department on the day of examination in 20% of patients, resulting in a need to reschedule the examination. Conclusions. Although not an easy task, implementation of the new guidelines for ICM use is both feasible and necessary. An additional refresher training course for personnel and GFR evaluation of the patient on referral are indispensable to ensure proper preparation of patients at increased risk of adverse reactions to ICM. 
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Introduction
Stimulated by the SIRM Emilia Romagna and Marche regional chapters and the experience of the Modena University Hospital and Hospital Trust (Protocollo sull'uso dei Mezzi di Contrasto 26/9/2001), the authors sought to implement the new national guidelines on the use of injectable iodinated contrast media (ICM) issued by SIRM (Italian Society of Medical Radiology) [1, 2] to prevent ICM toxicity at their institution. The project was presented and informally discussed with the institution's radiologists at two departmental meetings held in 2004 and 2005 , where the new documentation (patient history/screening form and informed consent form) was presented through a PowerPoint slide show (MGB, personal communication). One point that emerged from these preliminary meetings was the need to adopt a systematic approach to the problem of ICM, as its use is still governed by consolidated practice and there is some resistance to change. Our goals were to: 1. Provide information on the most recent scientific evidence on the subject 2. Critically review the list of laboratory tests ordered before ICM administration (for all patients: blood urea nitrogen, glucose, serum creatinine, serum protein and protein electrophoresis, urinalysis) 3. Provide information about the comorbidities capable of increasing the risk of reaction to ICM and to devise specific protocols for preventing organ damage and, where needed, for patient preparation 4. Create a tool capable of promoting the "sharing of responsibility" between the referring physician and the radiologist, as indicated in the Directive Euratom 43/97 and incorporated in our legislation [3] , by reviewing the patient history/screening form and informed consent form 5. Train radiology personnel in the first-line techniques and treatment to be used in the event of adverse reactions to ICM
Materials and methods
The available documentation (MGB, personal communication) was checked and reviewed by the relevant hospital specialists [a nephrologist (MC), an anaesthetist-resuscitator (SV), an endocrinologist (PP), specialists in legal medicine (MS, AR) and an allergologist (LB)] under the coordination 
Materiali e metodi

Il materiale a disposizione (M.G.B., comunicazione personale) è stato verificato e migliorato con le figure professionali ospedaliere di riferimento (nefrologo [M.C.], anestesista rianimatore [S.V.], endocrinologo [P.P.], medico
of a physician from hospital director staff (AV), an expert in informed consent forms [4] that were only recently adopted by our surgical divisions. During a series of meetings held in the first semester of 2006, the group jointly prepared the draft documentation that included the patient history/screening form (to be filled in by the referring physician and by the patient) and the informed consent form (to be filled in by the radiologist and patient during the routine interview before the examination). The group devised specific protocols for patients at risk of adverse reactions to ICM and/or for those requiring special preparation and identified the relevant contact telephone numbers to be given to the service users. In collaboration with the hospital's Public Relations Department (MFS), the new forms for radiological investigations, including those employing ICM, were posted on the hospital's Web site (www.asl11.marche.it/viewdoc. asp?CO_ID=6493), together with links to SIRM Web pages providing practical information on patient preparation for imaging studies (www.sirm.org/informazione_pazienti/ esami/) and the national guidelines [5] .
In collaboration with the hospital's Education and Training Department (SM), two training courses were developed to illustrate the draft document on ICM use, the national guidelines (with special reference to the appropriateness of imaging procedures, harmful effects of radiation exposure and ICM administration) and the patient history/screening and consent forms posted on the hospital Web site. All materials were supplied to the course participants as hypertexts on CD-ROM.
The first course, titled "Diagnostic Imaging: National Guidelines" [two afternoons for a total of 10 h, 10 continuing medical education (CME) credits] was repeated in two sessions (January and February 2007) and was addressed to medical, nursing and technical personnel of the Radiology Department. The same personnel were also enrolled in inhouse training sessions on first-aid techniques [BLS (basic life support) or BLSD (basic life support and defibrillation)]. In addition to hospital trolleys with emergency medications, diagnostic imaging rooms were also provided with kits containing specific drugs for adverse reactions to contrast media [chlorphenamine maleate (Trimeton 10 mg/ml vials, Schering-Plough); ranitidine chloride (Ranitidine Angenerico 50 mg/5 ml, Angelici); hydrocortisone (Flebocortid 1g/10 ml, Sanofi Aventis); methylprednisolone hemisuccinate (Urbason 40 mg/ml, Aventis); adrenaline IM (0.33 mg Fastjekt Adults, Merck; 0.165 mg Fastjekt Junior, Merck); and the telephone numbers of the anaesthetist-resuscitator for emergencies. Educational posters were put up in accordance with the Italian Society of Medical Radiology and Italian Society of Anesthesiology, Analgesia, Reanimation and Intensive Care recommendations [1] . American). On 10 May 2007, initial feedback was obtained at a meeting between the hospital director staff (AV), the radiologist (MGB) and several clinical directors (surgery, urology, oncology) who had experienced difficulties in applying the protocol, and the forms were reviewed. On 22 and 30 May 2007, two meetings were held between the hospital director staff, the radiologist, the reference nephrologist (MC) and endocrinologist (PP), the clinical director of the Clinical Laboratory Services (CC) and the union and scientific representatives of the general practitioners and community paediatricians of our area. The forms were further reviewed on the basis of feedback from the pilot phase and new evidence from the literature [7] . Proposals to improve the clarity and usability of the forms were incorporated, and procedures were established for arranging a nephrological consultation in selected cases and for admitting outpatients to the Nephrology and Dialysis Unit for treatment before and after contrast injection. The Radiology Department purchased an oven to heat the contrast medium to body temperature, weighing scales with a heightmeasuring rod, and a timer for timing the observation of patients after the examination with ICM (from a minimum of 30 min to a maximum of 60 min in high-risk patients).
During the first week of June, the radiologist (MGB) incorporated all revisions to produce a final draft of the patient history/screening form and informed consent form. On 12 June 2007, the final document was posted on the Hospital Trust Web site and transmitted to the hospital clinical directors, to the district directors and to the head of Primary Care Services (general practitioners and specialist services). 
Results
The training course "Diagnostic Imaging: National Guidelines" was successfully attended by 74.5% of the medical, nursing and technical staff of the Radiology Department (38 of 51 invited). The BLS or BLSD courses were successfully attended by 80% of the same personnel (44 of 55 invited). The training course "New Working Tools for Diagnostic Imaging" was successfully attended by 57.2% of doctors of our area (206 of 360 invited).
The final version of the document (available on our Hospital Trust's Web site www.asl11.marche.it/viewdoc. asp?CO_ID=6493>modulo mezzo di contrasto) consists of a two-sided page, one side containing the patient history/screening form for elective examinations with injectable ICM and the informed consent form, and the other providing guidance notes for completion and useful telephone numbers. The patient history/screening form, which is a compulsory requirement for the examination, must be filled in and signed by the referring physician and the patient. The form contains sections on indications for the examination and the patient's clinical data (inclusive of possible neoplasms and surgical operations), and any risk factors for the use of ICM. The only laboratory test required for all patients is serum creatinine. Limiting the required laboratory tests to serum creatinine alone allowed expenditure to be cut from 11.40 euro to 1.50 euro per patient (a saving of 86.8%).
Note 1 of the guidance notes explains that the patient's GFR should be calculated from serum creatinine using the formulas provided. If the GFR is less than 60 ml/min per 1.73 m 2 of body surface, a nephrological consultation must be arranged before the examination to prevent possible nephrotoxic damage. The Schwartz formula is used for children [8] [9] [10] : GFR=K×height (in cm) / serum creatinine (in mg/dl), where K is equal to 0.33 in preterm infants, 0.45 in term infants up to 1 year old, 0.55 in children up to 13 years old, 0.55 in adolescent females aged 13-18 years and 0.65 in adolescent males. For adults, among the various recommended methods [11, 12] , we decided to continue using the classic Cockcroft-Gault formula [13] , with which we are familiar. The formula was modified by replacing body weight in numerator position with ideal body weight (useful also in obese or pathologically underweight patients): GFR=[140-age (in years)] × ideal body weight (in kg) / [72 × serum creatinine (in mg/dl)]. In male patients, the result is multiplied by 1, in females it is multiplied by 0.85. Ideal body weight can be calculated as height (in cm) -100. For example, in normal-weight individuals, the threshold serum creatinine values are at 40 years: males>1.67, females>1.42; at 65 years: males>1.25; females>1.06; at 80 years: males>1.00, females>0.85.
During the preliminary stage of the project (April 1- [11, 12] , si è preferito continuare ad usare, per la "familiarità" che ne abbiamo, la clas- May 15, 2007) , the simplified MDRD formula was found to have overestimated the GFR in a number of elderly patients (above the threshold of 60 ml/min per 1.73 m 2 ) in comparison with the Cockcroft-Gault formula. As a result, in consideration of the number of examinations with ICM performed in patients older than 60 years at our centre (71%, and specifically, 57% of patients aged 61-80 years and 14% of patients aged over 80 years), the Clinical Laboratory Services have restricted the use of automatic GFR calculations from serum creatinine to patients aged 18-60 years only until a large enough case series has been collected to enable comparison of the two formulas across our patient population.
To date, at least 80% of patients have presented to the Radiology Department on the day of the examination without any indication of estimated GFR noted on the patient history/screening form by the referring physician, with no substantial difference between inpatients and outpatients. In all patients, the Radiology Department nursing and medical personnel independently evaluate this parameter, even when already calculated, by using the formulas reported on the back of the patient history/screening form.
On average 20% of patients scheduled for an examination with ICM have abnormal estimated GFR on the day of the examination (<60 ml/min per 1.73 m 2 , significant renal insufficiency). Patients with renal insufficiency are rescheduled and referred to the nephrology clinic for appropriate evaluation and preparation (nephrological assessment and prophylaxis for ICM-induced damage). The nephrologist assesses the patient for risk factors, quantifies the risk (Table 1 ) and prescribes the prophylactic treatment to be administered in connection with the examination, hydration with isotonic saline solution and administration of N-acetylcysteine. Table 1 is derived from a study on the intra-arterial administration of contrast medium [14] , which used a semiquantitative method for calculating contrast-induced risk. The fact that the risk of contrast-induced nephropathy may be higher with intra-arterial contrast administration [15] allows for a greater safety margin in our patients, who receive intravenous ICM. Inpatients undergo prophylactic treatment in the referring ward, whereas outpatients receive it at the nephrology clinic. In particular, with regard to hydration, our policy is to administer 0.9% saline solution intravenously at a dose of 1.0-1.5 ml/kg per hour, as suggested by the recent literature [16] . Whereas there is no problem starting the infusion 12 h before the examination and afterwards continuing it for at least 12 h in inpatients, in outpatients we are obliged to reduce administration times to 3 h before and 6 h after the examination. During hydration, each patient's cardiocirculatory compensation is evaluated clinically and, if necessary, corrected by the nephrologist [17] . In addition to hydration, patients receive 600 mg oral N-acetylcysteine twice daily the day before and the day of sica formula di Cockcroft-Gault [13] [18] . The usefulness of N-acetylcysteine in preventing contrast-induced nephropathy [19] is still being debated in the literature; however, until conclusive evidence becomes available, we believe it reasonable to continue its use, as it is inexpensive, simple to administer and free of side effects. If necessary, the nephrologist requests serum creatinine testing after the examination (at 12, 24, 36 or 48 di somministrazione intra-arteriosa del mezzo di contrasto [15] [18] . In letteratura l'utilità dell'acetilcisteina per la prevenzione della nefropatia da MdC è assai controverso [19] h); a 25% increase in serum creatinine within 3 days after contrast administration is considered to be contrast-induced nephropathy [20] . In addition, to prevent possible lactic acidosis [21] , diabetic patients receiving metformin are instructed to discontinue the medication 48 h before and not resume it until 48 h after the examination, after renal function has been evaluated. A "quick" prophylactic protocol has been developed for nonelective examinations (1.4% sodium bicarbonate: 3 ml/kg 1 h before ICM injection, followed by 1 ml/kg per hour for 6 h after ICM injection [22] keep still during the examination) Some of these situations are associated with specific patient-preparation protocols (reported in the guidance notes). These include hyperthyroidism (Table 2) , previous allergic reactions to iodinated substances and/or previous adverse reaction to ICM and severe asthma or allergy (evaluation by allergologist and anaesthesiologist before the day of the examination, with eventual desensitisation therapy prior to examination), need for sedation/general anaesthesia (preliminary evaluation by anaesthesiologist in uncooperative patients).
The patient history/screening form then reminds the referring physician and the patient of the need to bring along to the examination any previous relevant documentation and requests information on the patient's weight and height to dose the amount of ICM required. With regard to the maximum dose of contrast medium, it was reported almost 20 years ago that in the case of renal insufficiency, the maximum dose should be 5 ml of ICM per kilogram of body weight divided by the creatinine value [23] . This formula was proposed for the use of intra-arterial ICM. For currently [24] stated that in adults with normal renal function, the maximum recommended dose is 400 ml ICM (at a concentration of 300 mg of iodine per millilitre), whereas this amount should be drastically reduced in patients with renal insufficiency (150 ml if moderate, 100 ml if severe). Even the Contrast-Induced Nephropathy Consensus Working Panel recommended a dose of ICM less than 100 ml in patients with GFR <60 ml [15] . Duration of fasting prior to the examination with ICM was reduced to 6 h, in line with the current criteria for operating rooms. Finally, the patient is informed that it is inadvisable to repeat an examination with ICM before at least 1 week has passed after a previous ICM administration.
The patient history/screening form is followed by the informed consent form, to be filled in and signed during the verbal interview between the radiologist and patient prior to the examination.
Discussion
The aim of this paper is to share our experience in addressing the problem of ICM use so as to assist others seeking to tackle the same problem in their setting. The excellent and exhaustive material made available by SIRM [1, 2] regarding the new guidelines for the use of injectable contrast media had had insufficient uptake among both
Discussione
Lo scopo del presente lavoro è stato quello di voler condividere la nostra esperienza di fronte al "problema" dell'impiego dei MdC, perché possa essere di aiuto a chi si trovi nella propria realtà operativa a dover affrontare un'analoga situazione. L'ottimo ed esaustivo materiale pubblicato in ambito societario [1, 2] Evidence of manifest hyperthyroidism is a contraindication to the administration of iodinated contrast media.
Subjects at risk of thyrotoxicosis after iodinated contrast media (ICM) administration are patients with Basedow disease and multinodular toxic goitre, especially those living in areas with dietary deficiency of iodine and/or elderly patients.
Patients at risk should be monitored after ICM administration by means of thyroid-stimulating hormone (TSH) and FT4 testing, preferably by an endocrinologist.
In selected high-risk patients, TSH and FT4 testing may be performed, and prophylactic pharmacological treatment may be given prior to ICM administration. radiologists and referring physicians in our area, calling for a radical change in the approach to the problem (patient preparation, patient history/screening, informed consent, training of personnel in the management of adverse reactions to ICM). The issue of ICM use was thus revisited locally with all the professionals, other than radiologists, involved in the process (nephrologist, anaesthetist-resuscitator, endocrinologist, allergologist, legal medicine specialist, hospital management), an opportunity that was met with enthusiasm by all concerned. We experienced (and still experience) far more difficulty in sharing the project with other professionals. With regard to Radiology Department personnel, conceptually, the concerns and doubts aired at the meetings held in 2004 and 2005 were solved, with a good level of participation in the BLS and BLSD courses and the training course "Diagnostic Imaging: National Guidelines", which also served as a refresher course on indications for radiological procedures and the use of the various imaging modalities in individual clinical cases.
In practice, whereas GFR calculation has become routine practice at our Radiology Department, there are still problems with the 20% of patients who are found to have a pathological GFR on the day of the examination, causing major logistic difficulties in rescheduling the examinations to a date compatible with management of the patient's condition. The reason for this is, we believe, the fact that despite their moderately good level of participation in the course "New Working Tools for Diagnostic Imaging" and their extensive involvement in the project (through meetings with their scientific and union representatives), referring physicians still do not "feel" the problem of ICM use in a homogeneous manner. Preliminary evaluation of the GFR appears to be the cornerstone of the entire process of preventing ICM-induced toxicity, and advance GFR evaluation by the referring physician allows proper patient preparation to be planned. Failure to evaluate the GFR exposes the patient to the risk of not being able to undergo contrast administration on the day of the examination (scheduled with great difficulty given the normal waiting lists), with obvious consequences on patient care; on the other hand, it is difficult for the Radiology Department to reschedule examinations for which there is no alternative and that become increasingly "urgent" over time. We therefore believe that serum creatinine determination with GFR calculation needs to be done at the time of referral, whether examinations are performed on inpatients, urgent outpatients or elective outpatients. In the case of elective outpatients at risk for ICM-induced nephropathy, the test will be repeated at a date closer to the examination. Furthermore, we believe that another refresher course on the subject, scheduled for 2009 for both physicians and nurses in our area, may be more effective than sending out formal and informal reminders for them to fill in the patient history/ [27] ). A tal proposito screening sheet completely (including GFR calculation).
It should be emphasised that the prevalence of undetected renal insufficiency in the general population is high (GFR <60 ml=7.4% [25] ). This is particularly true in the elderly (renal function decreases "physiologically" by 1 ml/min per year after the age of 20-30 years [26] ) and in subjects with vascular disease or undergoing treatment with nephrotoxic agents (such as chemotherapy). On the other hand, it is important to minimise the risk of renal impairment due to the imprudent use of contrast media (ICM-induced nephrotoxicity is reported to be the third leading cause of acute renal failure in a hospital setting [27] ). For these reasons, we believe the protocol should necessarily involve the nephrologist for patients at risk. The possibility of a logistic support system in charge of prophylactic treatment before and after ICM administration, such as the one activated at our Nephrology and Dialysis Department, is thus essential.
Owing to the lack of agreement in the literature on the subject of nephrological consultation (only with GFR <30 ml [28] ; in all patients with GFR <60 ml [29, 30] ), we initially opted for nephrological consultation in all patients with GFR <60 ml. Although this involves a considerable workload, we prefer to screen all these patients for any changes in renal function induced by the use of ICM. The GFR threshold value required for nephrological consultation may be lowered in the future should it be demonstrated that this is not detrimental to the patient.
Because it is impossible to routinely request determination of actual GFR (measured as creatinine clearance=urine creatinine×urine volume in 1 min / serum creatinine), which requires 24-h urine collection, we decided to use the Cockcroft-Gault formula for GFR estimation [13] , which we have used successfully for many years. The method is also inexpensive (it requires only serum creatinine determination: cost=1.50 euro) and is thus suitable for screening purposes. Its main disadvantage, in our experience, is that it does not allow for the automatic calculation of GFR, as the hospital Clinical Laboratory does not record patients' weight and height. Another recently proposed formula is the MDRD [31] : GFR=170×(serum creatinine) Although this formula, which has been validated and is especially useful in patients with advanced renal insufficiency, allows for automatic evaluation of GFR by the Clinical Laboratory, it requires several determinations and is therefore more expensive (cost=4.5 euro). In addition, its comparison with the Cockcroft-Gault formula has yet to definitively demonstrate a better reliability, especially in the elderly [32] . The simplified MDRD formula [6] has recently been reported to be superior to the Cockcroft-Gault method by an authoritative paper [33] . This led us to perform an in-depth comparison of the Cockcroft-Gault and simplified MDRD formula in each patient in quindi riteniamo indispensabile l'attivazione di un percorso che coinvolga il nefrologo per i pazienti a rischio. La possibilità di un supporto logistico competente per il paziente ambulatoriale per la profilassi pre-e post-somministrazione di MdC, come quello da noi attivato presso la nefrologia e dialisi ospedaliera, risulta quindi essenziale.
Avendo ritrovato in letteratura dati discordanti sull'argomento (consulenza nefrologica solo con FG<30 [28] ; consulenza nefrologica in tutti i pazienti con FG<60 [29, 30] [32] . D'altra parte la formula MDRD semplificata [6] in un recente autorevole lavoro [33] Per quanto riguarda i tempi tra il dosaggio della creatininemia e l'espletamento dell'esame con MdC, nel modello our population. The data are still being collected and will be made the subject of another paper once a significant number has been reached.
With regard to the time interval between serum creatinine determination and ICM administration, although no definite interval is contemplated by the protocol (e.g. up to 1 month), the patient history/screening form does, nevertheless, request the date of the laboratory test to allow us to decide on a case-by-case basis: even 6 months is accepted for patients with good renal function [34] , and a maximum of 1 week for those with renal insufficiency.
As for the other risk factors, during the 1.5 months in which the protocol was piloted, we encountered problems related to thyroid function, with a transient explosion of requests for FT3, FT4 and thyroid-stimulating hormone (TSH) determinations that was unjustified by the patients' clinical situations. On this subject, the ESUR guidelines [35] state that, even in areas with dietary iodine deficiency, as is ours, there is no need to evaluate thyroid function before ICM administration in patients without clinical evidence of thyroid disease. Moreover, because the bottles of contrast medium always contain amounts of free iodine (much higher than the daily requirements), the ESUR considers patients with Basedow's disease and toxic nodular goitre as being at risk of developing thyrotoxicosis after ICM administration, especially those living in areas with dietary iodine deficiency and/or the elderly. Such patients will require monitoring of thyroid function after ICM administration. In exceptional cases, selected high-risk patients may require laboratory tests (at least TSH) before ICM administration, as well as prophylactic thyrostatic therapy (e.g. elderly patient with nodular goitre and heart disease).
Finally, with regard to collaboration with the anaesthetist-resuscitator, the ministerial circular of 17/09/97 [1] recommends only preliminary consultation with the anaesthesiologist and his/her presence in the hospital during the performance of examinations with ICM on patients at risk for adverse reactions. However, in consideration of the distance between the Radiology Department and the Operating Theatre Suite, we request that the anaesthesiologist is physically present in the Radiology Department during the examination. Infine, per quanto riguarda la collaborazione con l'anestesista-rianimatore, anche se la circolare ministeriale del 17/09/97 [1] ritiene opportuna la sola consultazione preventiva con l'anestesista e la sua disponibilità nel presidio ospedaliero in caso di esami con MdC in pazienti a rischio di reazione avversa, in questi casi la presenza fisica del collega in diagnostica è una consuetudine condivisa nella nostra struttura ospedaliera per l'eccessiva distanza attuale tra la Radiologia ed il Blocco operatorio dove è presente l'anestesista per le urgenze.
